 PRINCETON, N.J., Oct. 07, 2021 GLOBE NEWSWIRE -- Agile Therapeutics, Inc. Nasdaq: AGRX, a womens healthcare company, today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. All shares being offered are to be sold by Agile Therapeutics. The proposed offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. 